2020 VIRTUAL POSTER PRESENTATIONS

P01: Genome Editing with Third Generation Chemically Modified Oligonucleotides Without Programmable Nucleases, Presented by Tod W., Beth Israel Deaconess Medical Center

P02: Antisense Oligonucleotide (ASO)-Mediated Rescue of Protein Expression in Fibroblasts and Neurons Derived from a Patient with a Rare, Autosomal Recessive Neurological Disorder Caused by Loss-of-Function Mutations in the TECPR2 Gene, Presented by Luis W., Q-State Biosciences

P03: Development of Single Nucleotide Polymorphism-Distinguishable siRNA (SND-siRNA) Toward Therapeutic Application on Human Diseases, Presented by Kumiko U., University of Tokyo